Correspondence 0001493152-25-009323 from Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc.
Date: March 6, 2025 · CIK: 0001757499 · Accession: 0001493152-25-009323
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284889
Letter
WestPark Capital, Inc.
Century Park East, Suite 220
Los Angeles, CA 90067
March 6, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Shuttle Pharmaceuticals Holdings, Inc.
Registration Statement on Form S-1
File No. 333-284889
Acceleration Request
Requested Date: Friday, March 7, 2025
Requested Time: 4:30 PM Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), WestPark Capital, Inc., as representative of the underwriters of the offering, hereby joins the request of Shuttle Pharmaceuticals Holdings, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be accelerated so that it may become effective at 4:30 p.m., Eastern Time, on Friday, March 7, 2025, or as soon thereafter as practicable.
Pursuant to Rule 60 of the General Rules and Regulations under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended.
WESTPARK CAPITAL, INC.
Very
truly yours,
By:
/s/
Jason Stern
Show Raw Text
CORRESP
1
filename1.htm
WestPark
Capital, Inc.
1800
Century Park East, Suite 220
Los
Angeles, CA 90067
March
6, 2025
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Shuttle
Pharmaceuticals Holdings, Inc.
Registration
Statement on Form S-1
File
No. 333-284889
Acceleration
Request
Requested
Date:
Friday,
March 7, 2025
Requested
Time:
4:30
PM Eastern Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), WestPark
Capital, Inc., as representative of the underwriters of the offering, hereby joins the request of Shuttle Pharmaceuticals Holdings, Inc.
that the effective date of the above-referenced Registration Statement on Form S-1 be accelerated so that it may become effective at
4:30 p.m., Eastern Time, on Friday, March 7, 2025, or as soon thereafter as practicable.
Pursuant
to Rule 60 of the General Rules and Regulations under the Securities Act, please be advised that there will be distributed to each underwriter
or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended.
WESTPARK
CAPITAL, INC.
Very
truly yours,
By:
/s/
Jason Stern
Name:
Jason
Stern
Title:
Chief
Operating Officer